Sanofi (SNY) Revenue & Revenue Breakdown
Sanofi Revenue Highlights
Latest Revenue (Y)
$43.07B
Latest Revenue (Q)
$11.12B
Main Geography (Y)
Reportable Geographical Zones
Sanofi Revenue by Period
Sanofi Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $43.07B | -5.11% |
| 2022-12-31 | $45.39B | 15.86% |
| 2021-12-31 | $39.17B | 4.83% |
| 2020-12-31 | $37.37B | -0.70% |
| 2019-12-31 | $37.63B | 5.48% |
| 2018-12-31 | $35.68B | -1.50% |
| 2017-12-31 | $36.22B | 4.40% |
| 2016-12-31 | $34.70B | -0.47% |
| 2015-12-31 | $34.86B | 8.94% |
| 2014-12-31 | $32.00B | 2.26% |
| 2013-12-31 | $31.29B | -12.98% |
| 2012-12-31 | $35.96B | 2.56% |
| 2011-12-31 | $35.06B | 9.44% |
| 2010-12-31 | $32.03B | 4.18% |
| 2009-12-31 | $30.75B | 6.70% |
| 2008-12-31 | $28.82B | -1.49% |
| 2007-12-31 | $29.25B | -0.80% |
| 2006-12-31 | $29.49B | 3.50% |
| 2005-12-31 | $28.49B | 89.54% |
| 2004-12-31 | $15.03B | 87.10% |
| 2003-12-31 | $8.03B | 7.77% |
| 2002-12-31 | $7.46B | 14.91% |
| 2001-12-31 | $6.49B | 8.80% |
| 2000-12-31 | $5.96B | 11.46% |
| 1999-12-31 | $5.35B | - |
Sanofi generated $43.07B in revenue during NA 2023, up -5.11% compared to the previous quarter, and up 120.72% compared to the same period a year ago.
Sanofi Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $11.12B | -51.41% |
| 2023-12-31 | $22.88B | 80.21% |
| 2023-09-30 | $12.70B | 18.87% |
| 2023-06-30 | $10.68B | -1.67% |
| 2023-03-31 | $10.86B | -5.18% |
| 2022-12-31 | $11.46B | -12.80% |
| 2022-09-30 | $13.14B | 22.30% |
| 2022-06-30 | $10.74B | 6.85% |
| 2022-03-31 | $10.05B | -3.48% |
| 2021-12-31 | $10.41B | -3.82% |
| 2021-09-30 | $10.83B | 19.72% |
| 2021-06-30 | $9.04B | 1.79% |
| 2021-03-31 | $8.89B | -8.73% |
| 2020-12-31 | $9.74B | -1.45% |
| 2020-09-30 | $9.88B | 17.08% |
| 2020-06-30 | $8.44B | -9.42% |
| 2020-03-31 | $9.32B | -7.00% |
| 2019-12-31 | $10.02B | 0.97% |
| 2019-09-30 | $9.92B | 10.48% |
| 2019-06-30 | $8.98B | 3.06% |
| 2019-03-31 | $8.71B | -6.57% |
| 2018-12-31 | $9.33B | -4.29% |
| 2018-09-30 | $9.74B | 14.89% |
| 2018-06-30 | $8.48B | 4.37% |
| 2018-03-31 | $8.13B | -9.69% |
| 2017-12-31 | $9.00B | -4.21% |
| 2017-09-30 | $9.39B | 5.00% |
| 2017-06-30 | $8.95B | 0.55% |
| 2017-03-31 | $8.90B | -3.05% |
| 2016-12-31 | $9.18B | -1.27% |
| 2016-09-30 | $9.29B | 11.88% |
| 2016-06-30 | $8.31B | 4.79% |
| 2016-03-31 | $7.93B | 16.08% |
| 2015-12-31 | $6.83B | -29.44% |
| 2015-09-30 | $9.68B | 2.31% |
| 2015-06-30 | $9.46B | 6.42% |
| 2015-03-31 | $8.89B | -3.05% |
| 2014-12-31 | $9.17B | 3.41% |
| 2014-09-30 | $8.87B | 8.86% |
| 2014-06-30 | $8.15B | 2.79% |
| 2014-03-31 | $7.92B | -7.26% |
| 2013-12-31 | $8.54B | 0.32% |
| 2013-09-30 | $8.52B | 5.34% |
| 2013-06-30 | $8.09B | -0.87% |
| 2013-03-31 | $8.16B | -5.84% |
| 2012-12-31 | $8.66B | -6.24% |
| 2012-09-30 | $9.24B | 1.35% |
| 2012-06-30 | $9.12B | 2.01% |
| 2012-03-31 | $8.94B | 0.16% |
| 2011-12-31 | $8.92B | -2.71% |
| 2011-09-30 | $9.17B | 4.57% |
| 2011-06-30 | $8.77B | 7.07% |
| 2011-03-31 | $8.19B | 4.89% |
| 2010-12-31 | $7.81B | -5.44% |
| 2010-09-30 | $8.26B | 0.83% |
| 2010-06-30 | $8.19B | 5.35% |
| 2010-03-31 | $7.78B | 0.60% |
| 2009-12-31 | $7.73B | -0.55% |
| 2009-09-30 | $7.77B | -0.32% |
| 2009-06-30 | $7.80B | 4.64% |
| 2009-03-31 | $7.45B | -0.07% |
| 2008-12-31 | $7.46B | 4.06% |
| 2008-09-30 | $7.17B | 0.85% |
| 2008-06-30 | $7.10B | 0.14% |
| 2008-03-31 | $7.09B | -13.10% |
| 2007-12-31 | $8.16B | - |
Sanofi generated $11.12B in revenue during Q1 2024, up -51.41% compared to the previous quarter, and up 97.05% compared to the same period a year ago.
Sanofi Revenue Breakdown
Sanofi Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| North America | $19.22B | $18.98B | $15.07B | - | - |
| FRANCE | $2.38B | $2.30B | $2.26B | $2.22B | $2.26B |
| Europe | $10.39B | $10.00B | - | - | - |
| Reportable Geographical Zones | $43.07B | $43.00B | $37.76B | $36.04B | - |
| Other Countries | - | $14.01B | $12.93B | $12.83B | $13.90B |
| Europe 1 | - | - | - | $9.15B | $8.85B |
| North America 1 | - | - | - | $14.06B | $13.37B |
| Reportable geographical zones | - | - | - | - | $36.13B |
Latest
Sanofi's latest annual revenue breakdown by geography, as of Dec 23: Reportable Geographical Zones (57.38%), North America (25.60%), Europe (13.85%), and FRANCE (3.17%).
Quarterly Revenue by Country
| Country | Dec 23 | Jun 23 | Jun 22 |
|---|---|---|---|
| North America | $10.95B | $8.26B | $7.88B |
| FRANCE | $1.21B | $1.17B | $1.10B |
| Reportable Geographical Zones | $22.88B | $20.19B | $19.79B |
Latest
Sanofi's latest quarterly revenue breakdown by geography, as of Dec 23: Reportable Geographical Zones (65.31%), North America (31.26%), and FRANCE (3.44%).
Sanofi Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| JNJ | Johnson & Johnson | $85.15B | $22.47B |
| MRK | Merck | $60.12B | $16.66B |
| ABBV | AbbVie | $54.32B | $14.46B |
| NVS | Novartis | $46.66B | $11.83B |
| AZN | AstraZeneca | $45.81B | $12.68B |
| BMY | Bristol-Myers Squibb Company | $45.01B | $11.89B |
| SNY | Sanofi | $43.07B | $11.12B |
| GSK | GSK | $30.33B | $7.36B |
| AMGN | Amgen | $28.19B | $8.50B |
| GILD | Gilead Sciences | $27.12B | $7.55B |